Table 3.
Patients’ clinical characteristics at respiratory deterioration
| VAP n = 31 episodes | No-VAP n = 6 episodes | p | |
|---|---|---|---|
| Corrected age (weeks+days) * | 31+4 (4.2) | 29+6 (3.8) | 0.43 |
| Days at deterioration * | 44.93 (28.57) | 39 (31) | 0.56 |
| Weight at deterioration (grams) * | 1463 (692) | 1070 (350) | 0.22 |
| Days of ventilation (days) * | 41.32 (29.48) | 38 (32) | 0.79 |
| Number of intubation episodes * | 5.35 (3.48) | 4.3 (3.9) | 0.34 |
| Number of antibiotic courses * | 4.48 (3) | 3.3 (2.2) | 0.36 |
| Baseline FiO2 * | 0.44 (0.2) | 0.47 (0.32) | 0.67 |
| FiO2 at deterioration * | 0.69 (0.24) | 0.62 (0.26) | 0.32 |
| C-reactive protein at deterioration (mg/l) * | 11.3 (12.57) | 7.5 (2.12) | 0.97 |
| C-reactive protein repeat (mg/l) * | 21.68 (39.88) | 10.8 (14.44) | 0.72 |
| White cell count at deterioration (109/l) * | 27.15 (52.34) | 17.2 (0) | 0.62 |
| White cell count repeat (109/l) * | 15 (10.37) | 21 (10.74) | 0.23 |
*mean (standard deviation)
n number, VAP ventilator associated pneumonia